Development of Frataxin Gene Expression Measures for the Evaluation of Experimental Treatments in Friedreich’s Ataxia

• Heather L. Plasterer,

  Affiliation Repligen Corporation, Waltham, Massachusetts, United States of America

  ⨯
• Eric C. Deutsch,

  Affiliations Departments of Neurology and Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America, Divisions of Neurology and Pediatrics, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America

  ⨯
• Matthew Belmonte,

  Current address: Astra-Zeneca, Waltham, Massachusetts, United States of America

  Affiliation Repligen Corporation, Waltham, Massachusetts, United States of America

  ⨯
• Elizabeth Egan,

  Current address: Boston Children’s Hospital, Boston, Massachusetts, United States of America

  Affiliation Repligen Corporation, Waltham, Massachusetts, United States of America

  ⨯
• David R. Lynch ,

  * E-mail: lynchd@mail.med.upenn.edu (DRL); jrusche@repligen.com (JRR)

  Affiliations Departments of Neurology and Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America, Divisions of Neurology and Pediatrics, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America

  ⨯
• James R. Rusche

  * E-mail: lynchd@mail.med.upenn.edu (DRL); jrusche@repligen.com (JRR)

  Affiliation Repligen Corporation, Waltham, Massachusetts, United States of America

  ⨯